MNKD
NASDAQ · Biotechnology
Mannkind Corp
$4.11
+0.22 (+5.66%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+669.1% upside
Low Target
$20.51
Average Target
$31.61
High Target
$34.61
Current Price
$4.11
Current
$4.11
$4.11
Target
$31.61
$31.61
$20.51
$31.61 avg
$34.61
Scenario Analysis
Bear Case
$20.51
399.0%
Low target
Base Case
$31.61
+669.1%
Avg target
Bull Case
$34.61
+742.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.51
-36.9% from high
52-Week Low
$2.23
+84.3% from low
Target vs 52W High
$31.61
+385.6% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
2d
until earnings
EPS Est: $0.00
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |